Main Session
Sep
28
QP 14 - Modernizing Definitive Therapy in Cervical Cancer: From Systemic Intensification to Adaptive Radiation
1078 - Bone Marrow-Sparing Extended-Field Chemoradiation with Dose-Dense Neoadjuvant Chemotherapy for FIGO 2018 Stage IIIC2 Cervical Cancer: Early Outcomes of a Prospective Phase II Study
Presenter(s)
Surendra Kumar Saini, MD - ALL INDIA INSTITUTE OF MEDICAL SCIENCES,NEW DELHI,INDIA, NEW DELHI,